Concepedia

Absorption Lag Model

The Absorption Lag Model is a pharmacokinetic model that characterizes the time delay between drug administration and the onset of systemic absorption by incorporating a lag time parameter into the absorption phase dynamics.

36

Publications

938

Citations

167

Authors

65

Institutions

Publications per year

2017–2026

6

Parents

Publications

36

Population Pharmacokinetics of Eltrombopag in Healthy Subjects and Patients With Chronic Idiopathic Thrombocytopenic Purpura

Ekaterina Gibiansky, Jianping Zhang, Daphne Williams et al. · The Journal of Clinical Pharmacology · 2010 · 86 citations

, , +17

Population pharmacokinetics of dolutegravir in HIV‐infected treatment‐naive patients

Jianping Zhang, Siobhán Hayes, Brian M. Sadler et al. · British Journal of Clinical Pharmacology · 2015 · 82 citations · Full text

, , +17

Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group

Gareth J. Veal, Michael Cole, Julie Errington et al. · British Journal of Cancer · 2007 · 58 citations · Full text

, , +14

ROOT RESISTANCE AS A CAUSE OF THE ABSORPTION LAG

Paul J. Kramer · American Journal of Botany · 1938 · 49 citations

, , +7

Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures

Howard N. Bockbrader, Paula Burger, Lloyd Knapp et al. · Epilepsia · 2011 · 43 citations · Full text

, , +16

1–5 of 36

Authors

167

  1. YH
    Yukiya Hashimoto

    Kyoto University Hospital, Japan

    2 publications · 35 citations

    2

    h-index

  2. TJ
    Timothy J. Carrothers

    Allergan (United States), United States

    2 publications · 45 citations

    2

    h-index

  3. PJ
    Paul J. Kramer

    Duke University, United States

    2 publications · 71 citations

    2

    h-index

  4. DE
    Daniel E. Salazar

    Daiichi Sankyo (United States), United States

    2 publications · 45 citations

    2

    h-index

  5. TK
    Tatiana Khariton

    Institute for Clinical Pharmacodynamics (United States), United States

    2 publications · 45 citations

    2

    h-index

1–5 of 167

Institutions

65

  1. Pfizer (United States)

    New York, United States

    2 h-index

    8 publications

    296 citations

  2. University of South Australia

    Adelaide, Australia

    2 h-index

    8 publications

    103 citations

  3. Johns Hopkins University

    Baltimore, United States

    2 h-index

    3 publications

    65 citations

  4. Otsuka (Japan)

    Tokyo, Japan

    2 h-index

    10 publications

    137 citations

  5. HealthInsight

    Salt Lake City, United States

    2 h-index

    5 publications

    112 citations

  6. Mercer University Health Sciences Center

    Savannah, United States

    2 h-index

    4 publications

    100 citations

  7. Environmental and Occupational Health Sciences Institute

    Piscataway, United States

    2 h-index

    8 publications

    224 citations

  8. GlaxoSmithKline (United States)

    Philadelphia, United States

    2 h-index

    5 publications

    418 citations

1–8 of 65

Venues

  1. Antimicrobial Agents and Chemotherapy

    AAC · 5 publications · 82 citations

    5

    h-index

  2. The Journal of Clinical Pharmacology

    5 publications · 197 citations

    5

    h-index

  3. Biological and Pharmaceutical Bulletin

    4 publications · 68 citations

    4

    h-index

  4. British Journal of Clinical Pharmacology

    BJCP · 4 publications · 153 citations

    4

    h-index

  5. Risk Analysis

    2 publications · 56 citations

    2

    h-index

1–5